Written by: Philip P. Storey, MD Feb 2021 Samir N. Patel, MD, Philip P. Storey, MD, MPH, Hannah Levin, BS, Maitri Pancholy, MD, Anthony Obeid, MD, MPH, Turner D. Wibbelsman, BS, Brandon Kuley, BA, Allen C. Ho, MD, Jason Hsu, MD, Sunir J. Garg, MD, James F. Vander, MD, James P. Dunn, MD. Ophthalmology Retina […]
Written by: Wenlan (Wendy) Zhang, MD January 2021 Spooner KL, Fraser-Bell S, Cozzi M, Staurenghi G, Invernizzi A, Monteduro D, Munk MR, Hong T, Chang AA. Macular Atrophy Incidence and Progression in Eyes with Neovascular Age-Related Macular Degeneration Treated with Vascular Endothelial Growth Factor Inhibitors Using a Treat-and-Extend or a Pro Re Nata Regimen: Four-Year Results of […]
Written by: Andrew Tye, MD January 2021 Wang JC, Ryan EH, Ryan C, Kakulavarapu S, Mardis PJ, Rodriguez M, Stefater JA, Forbes NJ, Gupta O, Capone A Jr, Emerson GG, Joseph DP, Eliott D, Yonekawa Y; Primary Retinal Detachment Outcomes (PRO) Study Group. FACTORS ASSOCIATED WITH THE USE OF 360-DEGREE LASER RETINOPEXY DURING PRIMARY VITRECTOMY […]
Written by: Priya Sharma Vakharia, MD Jan 2021 Mammo DA, Ringeisen AL, Parke DW. Frequency of rhegmatogenous retinal detachment after intravitreal therapy in neovascular age-related macular degeneration. Ophthalmology Retina 2020; 4:973-8. The purpose of this study was to look at patients who developed rhegmatogenous retinal detachment (RRD) within 90 days of intravitreal injection for neovascular […]
Written by: Daniel Su, MD December 2020 Ali FS, Jenkins TL, Boparai RS, Obeid A, Ryan ME, Wibblesman TD, Chiang A, Garg SJ; Post-Injection Endophthalmitis (PIE) Study Group. Aqueous Chlorhexidine Compared to Povidone Iodine as Ocular Antisepsis Prior to Intravitreal Injection: A Randomized Clinical Trial. Ophthalmol Retina. 2020 Nov 19:S2468-6530(20)30458-9 Topical providone iodine (PI) is […]
Written by: Mohsin H. Ali, MD December 2020 Keenan TDL, Clemons TE, Domalpally A, Elman MJ, Havilio M, Agrón E, Benyamini G, Chew EY. Retinal Specialist versus Artificial Intelligence Detection of Retinal Fluid from OCT: Age-Related Eye Disease Study 2: 10-Year Follow-On Study. Ophthalmology. 2020 Jun 27:S0161-6420(20)30580-7. doi: 10.1016/j.ophtha.2020.06.038. Epub ahead of print. PMID: 32598950. […]
Written by: Rehan M. Hussain, MD December 2020 Gabrielle PH, Nguyen V, Wolff B, et al. Intraocular Pressure Changes and Vascular Endothelial Growth Factor Inhibitor Use in Various Retinal Diseases: Long-Term Outcomes in Routine Clinical Practice: Data from the Fight Retinal Blindness! Registry. Ophthalmol Retina 2020 Sep;4(9):861-870. doi: 10.1016/j.oret.2020.06.020. Epub 2020 Jun 20. It is well […]
Written by: Akshay S. Thomas, MD November 2020 Besirli CG, Smith SJ, Zacks DN, Gardner TW, Pipe KP, Musch DC, Shah AR. Randomized Safety and Feasibility Trial of Ultra-Rapid Cooling Anesthesia for Intravitreal Injections. Ophthalmol Retina. 2020 Oct;4(10):979-986. doi: 10.1016/j.oret.2020.04.001. Epub 2020 Apr 15. PMID: 32446842; PMCID: PMC7541410. Intravitreal injection is by far the most […]
